Trial intelligence / Profile preview

DFD-01 Spray HPA Axis Suppression in Adolescent Psoriasis

NCT02070965Phase 2Completed

Sponsor
Primus Pharmaceuticals
Start
Jan 2014
Primary completion
Oct 2014
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of betamethasone dipropionate spray 0.05% in plaque psoriasis, sponsored by Primus Pharmaceuticals. Started Jan 2014; status: completed.

02

Drugs

betamethasone dipropionate spray 0.05%
03

Conditions

plaque psoriasis

Beyond the preview

Go deeper on NCT02070965.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02070965.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call